<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>From Tokens to Blocks: A Block-Diffusion Perspective on Molecular Generation - Health AI Hub</title>
    <meta name="description" content="SoftMol is a novel framework addressing limitations in existing GPT-based molecular language models (MLMs) for drug discovery, particularly their inadequate cap">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>From Tokens to Blocks: A Block-Diffusion Perspective on Molecular Generation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.21964v1" target="_blank">2601.21964v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-29
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Qianwei Yang, Dong Xu, Zhangfan Yang, Sisi Yuan, Zexuan Zhu, Jianqiang Li, Junkai Ji
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.21964v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.21964v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">SoftMol is a novel framework addressing limitations in existing GPT-based molecular language models (MLMs) for drug discovery, particularly their inadequate capture of molecular graph structures and lack of explicit target-aware generation. It introduces a block-diffusion approach using "soft fragments" and a gated Monte Carlo tree search, significantly improving chemical validity, binding affinity, molecular diversity, and inference efficiency for de novo molecular design.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to medicine as it provides a significantly more efficient and effective computational tool for de novo drug design, accelerating the discovery of novel drug candidates and potentially shortening the overall drug development timeline.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is the de novo generation of novel molecular structures with desired drug-like properties and improved binding affinity, using deep generative models (specifically a block-diffusion molecular language model combined with a Monte Carlo tree search). This aims to accelerate and enhance the early stages of drug discovery by efficiently exploring chemical space and designing potential drug candidates.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>SoftMol is a unified framework co-designing molecular representation, model architecture, and search strategy for target-aware molecular generation, addressing core limitations of existing MLMs.</li>
                    
                    <li>It introduces "soft fragments," a rule-free block representation of SMILES strings, enabling diffusion-native modeling of molecular structures.</li>
                    
                    <li>SoftBD, the core model, is the first block-diffusion molecular language model, combining local bidirectional diffusion with autoregressive generation while adhering to molecular structural constraints.</li>
                    
                    <li>The model is trained on ZINC-Curated, a specialized dataset designed to favor the generation of molecules with high drug-likeness and synthetic accessibility.</li>
                    
                    <li>A gated Monte Carlo tree search (MCTS) is integrated into SoftMol to intelligently assemble fragments in a target-aware manner, optimizing for desired molecular properties.</li>
                    
                    <li>Experimental results demonstrate SoftMol achieves 100% chemical validity, a 9.7% improvement in binding affinity, a 2-3x increase in molecular diversity, and a 6.6x speedup in inference efficiency compared to state-of-the-art models.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>SoftMol employs a multi-faceted approach: (1) **Molecular Representation**: Utilizes "soft fragments," a novel rule-free block representation of SMILES strings, facilitating diffusion modeling. (2) **Model Architecture**: Develops SoftBD, a block-diffusion molecular language model that integrates local bidirectional diffusion for global structure capture with autoregressive generation for local refinement, enforcing molecular structural constraints. (3) **Training**: Trained on ZINC-Curated, a dataset optimized for drug-likeness and synthetic accessibility. (4) **Search Strategy**: Integrates a gated Monte Carlo tree search (MCTS) to assemble fragments in a target-aware manner, guiding the generation process towards molecules with desired properties.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>SoftMol achieved 100% chemical validity in generated molecules. It demonstrated a 9.7% improvement in binding affinity, suggesting more potent candidate compounds. The model also delivered a 2-3x increase in molecular diversity, enabling broader exploration of chemical space, and a substantial 6.6x speedup in inference efficiency, significantly reducing computation time for molecular generation.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By dramatically improving the efficiency and quality of de novo molecular design, SoftMol can significantly streamline the initial stages of drug discovery. This could lead to faster identification of promising lead compounds, reduce the need for extensive experimental screening, and ultimately accelerate the development of new therapies and drugs for various diseases, bringing them to patients more quickly and cost-effectively.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract primarily highlights the fundamental limitations of *existing* GPT-based molecular language models (inadequate graph structure capture, lack of target-aware mechanisms) which SoftMol aims to overcome. It does not explicitly state specific limitations or caveats of the SoftMol framework itself.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated in the abstract, potential future directions could include extending SoftMol to optimize for a broader range of multi-objective properties beyond binding affinity (e.g., ADMET properties), integrating experimental feedback loops for iterative refinement, and applying this block-diffusion paradigm to other biological sequence or graph generation challenges.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">pharmaceutical research</span>
                    
                    <span class="tag">medicinal chemistry</span>
                    
                    <span class="tag">drug design</span>
                    
                    <span class="tag">pharmacology</span>
                    
                    <span class="tag">computational biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">molecular generation</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">deep generative models</span>
                    
                    <span class="tag tag-keyword">block-diffusion</span>
                    
                    <span class="tag tag-keyword">molecular language models</span>
                    
                    <span class="tag tag-keyword">SMILES</span>
                    
                    <span class="tag tag-keyword">Monte Carlo tree search</span>
                    
                    <span class="tag tag-keyword">target-aware generation</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Drug discovery can be viewed as a combinatorial search over an immense chemical space, motivating the development of deep generative models for de novo molecular design. Among these, GPT-based molecular language models (MLM) have shown strong molecular design performance by learning chemical syntax and semantics from large-scale data. However, existing MLMs face two fundamental limitations: they inadequately capture the graph-structured nature of molecules when formulated as next-token prediction problems, and they typically lack explicit mechanisms for target-aware generation. Here, we propose SoftMol, a unified framework that co-designs molecular representation, model architecture, and search strategy for target-aware molecular generation. SoftMol introduces soft fragments, a rule-free block representation of SMILES that enables diffusion-native modeling, and develops SoftBD, the first block-diffusion molecular language model that combines local bidirectional diffusion with autoregressive generation under molecular structural constraints. To favor generated molecules with high drug-likeness and synthetic accessibility, SoftBD is trained on a carefully curated dataset named ZINC-Curated. SoftMol further integrates a gated Monte Carlo tree search to assemble fragments in a target-aware manner. Experimental results show that, compared with current state-of-the-art models, SoftMol achieves 100% chemical validity, improves binding affinity by 9.7%, yields a 2-3x increase in molecular diversity, and delivers a 6.6x speedup in inference efficiency. Code is available at https://github.com/szu-aicourse/softmol</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>30 pages, 13 figures, 11 tables</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>